Abstract C032: PRC2 inhibition enhances AR inhibitor response to delay treatment relapse in castration-sensitive prostate cancer by restricting adaptation of tumor cells in preclinical studies
Year: 2025
Type: conference-abstract
Source: Molecular Cancer Therapeutics
Authors: Natalie Yuen, Aleksandr Pankov, Livia Ulicna, Jason E. Long, Xi Chen, Gina Andreatta, Amber W. Wang, Lori S. Friedman, Anneleen Daemen, Melissa R. Junttila
Institution: ORIC Pharmaceuticals, Inc. (United States)
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4415444576
Cites:
Cited by:
Related to: